Cat.#: ACPP-1206
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1153 | MERTK Blocking Peptide (AC1153) | 250 µg | inquiry |
| ACPP-1477 | Mouse I TAC Protein (AC1477) | 5 µg | inquiry |
| ACPP-1787 | Exenatide (AC1787) | 1 mg | inquiry |
| ACPP-1581 | Rat FGF 9 Protein (AC1581) | 2 µg | inquiry |
| ACPP-1300 | GTP cyclohydrolase 1 Blocking Peptide (AC1300) | 250 µg | inquiry |
| ACPP-1214 | Ki67 Blocking Peptide (AC1214) | 250 µg | inquiry |
| ACPP-1577 | Human WWOX Protein (AC1577) | 2 µg | inquiry |
| ACPP-1003 | Recombinant Human NOTCH3 Protein (Fc Tag) (AC1003) | 50 µg | inquiry |
| ACPP-1324 | Insulin Receptor Blocking Peptide (AC1324) | 250 µg | inquiry |
| ACPP-1622 | Human DLK1 Protein (AC1622) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.